Home / GLAXO.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does GLAXO.NS make money? Does GLAXO.NS have pricing power? What's the Earnings Whisper? Will GLAXO.NS profit more as the business scales? What is GLAXO.NS's management track record? Is GLAXO.NS's current price justified?

GlaxoSmithKline Pharmaceuticals Limited

₹2566.1 +$110.20 (+4.49%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹2524.7

Day Range

₹2518.4₹2573.2

Year Range

₹2088.1₹3120.7

Market Cap

434.71B

AVG Volume

115.32K

Trailing/Forward PE

40.7/31.93

PEG ratio

3.67

Dividend Yield

2.22%

Next Earnings Date

2026-11-03

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

GLAXO.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	39.55B
26 Q4	38.22B
26 Q3	37.78B
26 Q2	36.86B
26 Q1	37.17B
25 Q4	37.26B
25 Q3	36.93B
25 Q2	35.49B
25 Q1	34.95B
24 Q4	34.42B

Net Income (INR) · TTM

GLAXO.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	10.68B
26 Q4	10.36B
26 Q3	10.21B
26 Q2	9.55B
26 Q1	9.5B
25 Q4	9.28B
25 Q3	8.59B
25 Q2	6.75B
25 Q1	6.4B
24 Q4	5.9B

Operating Income (INR) · TTM

GLAXO.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	12.87B
26 Q4	12.43B
26 Q3	12.27B
26 Q2	11.49B
26 Q1	11.36B
25 Q4	11.14B
25 Q3	10.31B
25 Q2	9.59B
25 Q1	9.25B
24 Q4	8.38B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

GlaxoSmithKline Pharmaceuticals Limited

Video analysis: GLAXO.NS

News: GLAXO.NS

Similar companies